High profile junk reporting is going to sell a lot of this junk vaccine — buyer beware!

The New York crimes

Apparently, it’s not hard to dupe the simple-minded editors of The New York Times.

A Merck & Co. strategy did it without breaking a sweat. They easily conned the Times into giving free publicity for a vilified vaccine.

Wait — it gets even more laughable.

The Times actually made claims about the drug that the FDA won’t allow Merck to make.

Amazing. Merck literally got publicity they couldn’t have paid for if they’d wanted to.

Empty-headed headline

In case you’ve somehow managed to avoid it up to this point, Gardasil is Merck’s HPV vaccine.

As I’ve often pointed out, researchers still have no idea how effective Gardasil might be. Apparently it reduces rates of genital warts. But that’s not exactly a national health crisis.

As for HPV prevention, there is no clinical proof that it’s widely effective. So anytime you hear some pinheaded do-gooder calling Gardasil a “lifesaver,” you know he’s stretching the truth way past breaking.

Meanwhile, this vaccine is an invitation to disaster. The FDA has received thousands of adverse event reports. They range from fainting to permanent disabilities. Dozens of girls who have experienced these events have died.

So Merck needs all the help they can get selling this junk.

Fortunately for them, there are plenty of nitwits standing by, ready to lend a hand.

Merck recently launched a program to supply Gardasil to the poorest countries for just $4.50 per dose. Here in the U.S., the three doses cost nearly $400.

So while Merck gets to look like the HPV vaccine Santa Claus, stand back and let the ridiculous gushing begin…

The World Health Organization called it “a great step forward for women and girls.”

I think the Times editors must have thought, “Oh we can top that!” And they did…

Completely fact-free, the Times claims millions of girls will be “protected against a major deadly cancer.” And they say it could lead to a “significant advance in women’s health.”

They must be taking Ambien at the Times because they’re sleepwalking and yammering nonsense.

But here’s the capper…

The Times headline refers to Gardasil as a “cancer vaccine.”

Nope. Wrong! It’s an HPV vaccine. And IF it works, then — in theory — it might prevent SOME, certainly not all, cases of cervical cancer.

That’s why Merck can’t call it a cancer vaccine in ads or on the Gardasil website. Because it’s not.

But the Times can say it! They can put it in the headline and promote this 100 percent phony claim. Then doctors can show the headline to parents of middle school kids. And many of those parents will just shrug and say, “Hey. It’s The New York Times. Must be true.”

Not even close. It’s junk reporting for a junk vaccine.

You can find out how to REALLY protect your daughters and granddaughters from cervical cancer here.

Sources:
“Cancer Vaccines Get a Price Cut in Poor Nations” Donald G. McNeil, Jr., The New York Times, 5/9/13, nytimes.com